Results 211 to 219 of about 78,101 (219)

MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates

Diagnostic Microbiology and Infectious Disease, 2009
Philip J Turner
exaly  

The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest® and time-kill assay

Diagnostic Microbiology and Infectious Disease, 2009
George Pankey
exaly  

Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model

Carbohydrate Polymers, 2017
Omaima El Gazayerly, Ayat Abdelkader, Mohamed A El-Mokhtar   +2 more
exaly  

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Rodrigo Mendes, Michael Huband, Mariana Castanheira   +2 more
exaly  

Microbiological assay for the determination of meropenem in pharmaceutical dosage form

Journal of Pharmaceutical and Biomedical Analysis, 2005
Elfrides Schapoval, Andreas Méndez
exaly  

Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic concepts

American Journal of Health-System Pharmacy, 2004
David Nicolau, Joseph Kuti, Charles H Nightingale   +2 more
exaly  

Meropenem therapy failure in Listeria monocytogenes infection

European Journal of Clinical Microbiology and Infectious Diseases, 2004
S Stepanovic
exaly  

Meropenem: clinical response in relation to in vitro susceptibility

Clinical Microbiology and Infection, 2000
G L Drusano, J R Edwards
exaly  

Meropenem-resistant Burkholderia pseudomallei: a concerning single case in Australia with no prior meropenem exposure

Access Microbiology
Ian Gassiep, Robert Norton, Matthew Glover   +2 more
exaly